"IMPACT OF MEAN ARTERIAL PRESSURES MAINTAINED DURING CARDIOPULMONARY BYPASS ON POST-OPERATIVE LACTATE LEVELS IN CORONARY ARTERY BYPASS GRAFTING PATIENTS".

Main Article Content

Dr. Sushma Nandipati
Ms. Kaviya .C
Dr. K. Koushik MBBS
Mr. G. John Jude B.Sc
Dr. S. Balachandran., M.S.,M.Ch

Keywords

MAP, CPB, CABG, Lactate

Abstract

Lactate, a byproduct of anaerobic metabolism is produced when the body breaks down glucose for energy. The problem with this is that it can build up in the blood stream more quickly than it is eliminated. Lactate is noted to be a marker for cellular hypoxia and tissue hypoperfusion. By monitoring lactate, patients who have an increased risk of post-operative morbidity and mortality can be identified and they may benefit from early aggressive intervention.  Hyperlactatemia during cardio pulmonary bypass (CPB) appears to be related mainly to insufficient oxygen delivery and blood flow. This study was aimed to show the impact of mean arterial pressure (MAP) during CPB on the patient’s blood lactate level and post-operative outcomes. 40 patients undergoing coronary artery bypass grafting (CABG) surgery were enrolled for the study. The patients were blindly divided into 2 groups based on the target mean arterial pressure set, as Group-1 [40-60mm Hg] and Group-2 [61-80mm Hg]. All patients underwent CABG surgery on CPB. Perfusion flow rates are well maintained throughout the surgery. Lactate levels, Hemodynamic parameters and Post-operative outcomes of the patients were noted. Results revealed that the Lactate level in Group-2 was low as compared to the Group-1 after surgery. Early extubation and speedy recovery of the patients are also seen in Group-2 patients. This study shows high MAP of 61-80mm Hg during CPB could decrease the blood lactate level and tissue hypoxia.

Abstract 50 | pdf Downloads 33

References

1. Panyun Wu, Tengteng Zhu, Yi. Current understanding of the contribution of lactate to the cardiovascular system and its therapeutic relevance. Front. Endocrinol.,15 June 2023, Volume 14 – 2023.
2. Annis Seghrouchni, Noureddine Atmani Younes Moutakiallah et.al., Does severe hyperlactatemia during cardiopulmonary bypass predict a worse outcome? Annals of Medicine and Surgery . Volume 73, January 2022,103198.
3. Demers P, Elkouri S, Martineau R, Couturier A, Cartier R. Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation. Ann Thorac Surg [Internet]. 2000 Dec 1 [cited 2022 Feb 27];70(6):2082–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003497500021603.
4. Matteucci M, Ferrarese S, Cantore C, Cappabianca G, Massimi G, Mantovani V, et al. Hyperlactatemia during cardiopulmonary bypass: risk factors and impact on surgical results with a focus on the long-term outcome. Perfusion. 2020 Nov;35(8):756–62.
5. Govender P, Tosh W, Burt C, Falter F. Evaluation of Increase in Intraoperative Lactate Level as a Predictor of Outcome in Adults After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2020 Apr 1;34(4):877–84.
6. Yang HH, Chang JC, Jhana JY, Cheng YT, Huang YT, Chang BS, et al. Prognostic value of peak lactate during cardiopulmonary bypass in adult cardiac surgeries: A retrospective cohort study. Tzu chi Med J [Internet]. 2020 Oct 1 [cited 2023 Feb 9];32(4):386–91. Available from: https://pubmed.ncbi.nlm.nih.gov/33163386/
7. Kapoor PM, Mandal B, Chowdhury UK, Singh SP, Kiran U. Changes in myocardial lactate, pyruvate and lactate-pyruvate ratio during cardiopulmonary bypass for elective adult cardiac surgery: Early indicator of morbidity. J Anaesthesiol Clin Pharmacol [Internet]. [cited 2022 Nov 11];27(2). Available from: www.joacp.org
8. Redant S, Hussein H, Mugisha A, Attou R, Bels D De, Honore PM, et al. Differentiating hyperlactatemia type A from type B: How does the lactate/pyruvate ratio help? J Transl Intern Med. 2019;7(2):43–5.
9. Smith ZR, Horng M, Rech MA. Medication-Induced Hyperlactatemia and Lactic Acidosis: A Systematic Review of the Literature. Pharmacother J Hum Pharmacol Drug Ther [Internet]. 2019 Sep 1 [cited 2022 Nov 12];39(9):946–63. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/phar.2316
10. Vedel AG, Holmgaard F, Rasmussen LS, Langkilde A, Paulson OB, Lange T, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: A randomized controlled trial. Circulation. 2018;137(17):1770–80.
11. Hori D, Nomura Y, Ono M, Joshi B, Mandal K, Cameron D, et al. Optimal blood pressure during cardiopulmonary bypass defined by cerebral autoregulation monitoring. J Thorac Cardiovasc Surg. 2017 Nov 1;154(5):1590-1598.e2.
12. Minton J, Chb F;, Sidebotham DA. Hyperlactatemia and Cardiac Surgery. J Extracorpor Technol. 2017;49:7–15.
13. Ozgoz HM, Yuksel A, Tok M, Bicer M, Signak IS. Relationship between Serum Lactate Levels and Postoperative Outcomes in Patients undergoing On-Pump Coronary Bypass Surgery. Int J Clin Cardiol Res [Internet]. 2017;1(1):015–9. Available from: www.scireslit.com
14. Godinjak A, Jusufovic S, Rama A, Iglica A, Zvizdic F, Kukuljac A, et al. Hyperlactatemia and the Importance of Repeated Lactate Measurements in Critically Ill Patients. Med Arch (Sarajevo, Bosnia Herzegovina). 2017 Dec;71(6):404–7.
15. Aleksandar J, Vladan P, Markovic-Jovanovic S, Stolic R, Mitic J, Smilic T. Hyperlactatemia and the Outcome of Type 2 Diabetic Patients Suffering Acute Myocardial Infarction. 2016 [cited 2022 Nov 12]; Available from: http://dx.doi.org/10.1155/2016/6901345.
16. Satoko Noguchi, Junichi Saito, Kazuyoshi Hirota et.a;., Lactate level during cardiopulmonary bypass as a predictor of postoperative oucomes in adult patients undergoing cardiac surgery. JA Clinical Reports, 24 November 2016.
17. J.R. Renew, D.W.Barbara, J.A.Hyder, et.al., Frequency and outcomes of severe hyperlactatemia after elective cardiac surgery. J.Thorac.Cardiovasc.Surg.,151(2016), pp.825-830
18. Jabbari A, Banihashem N, Alijanpour E, Vafaey HR, Alereza H, Rabiee SM. Serum lactate as a prognostic factor in coronary artery bypass graft operation by on pump method. Casp J Intern Med. 2013;4(2):662–6.
19. E.O’Connor, J.F. Fraser, et.al., The interpretation of perioperative lactate abnormalities in patients undergoing cardiac surgery. Anaesth.Intensive care, 40(4) (2012 jul), pp.598-603.
20. Ranucci M, De Toffol B, Isgrò G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: Determinants and impact on postoperative outcome. Crit Care. 2006;10(6):1–9.
21. Plestis KA, Gold JP. Importance of blood pressure regulation in maintaining adequate tissue perfusion during cardiopulmonary bypass. Semin Thorac Cardiovasc Surg. 2001 Apr;13(2):170–5.
22. Gold JP, Charlson ME, Williams-Russo P, Szatrowski TP, Peterson JC, Pirraglia PA, et al. Improvement of outcomes after coronary artery bypass: A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110(5):1302–14.
23. Andersson LG, Bratteby LE, Ekroth R, Hallhagen S, Joachimsson PO, van der Linden J, et al. Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure. Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg. 1994;8(11):597–602.
24. Rashkin MC, Bosken C, Baughman RP. Oxygen Delivery in Critically III Patients. Chest [Internet]. 1985 May 1 [cited 2022 Feb 27];87(5):580–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0012369215411730.
25. Chaitman BR, Fisher LD, Bourassa MG, Davis K, Rogers WJ, Maynard C, et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol. 1981 Oct;48(4):765–77.